Abatacept (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Abatacept" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2web.archive.org

1^st place

1^st place

2medicines.org.uk

3,823^rd place

2,387^th place

2^nd place

2^nd place

2semanticscholar.org

11^th place

8^th place

447^th place

338^th place

68^th place

117^th place

1healthvalue.net

low place

low place

doi.org

Moreland L, Bate G, Kirkpatrick P (2006). "Abatacept". Nature Reviews Drug Discovery. 5 (3): 185–186. doi:10.1038/nrd1989. PMID 16557658. S2CID 266176720.
Dall'Era M, Davis J (2004). "CTLA4Ig: a novel inhibitor of co-stimulation". Lupus. 13 (5): 372–376. doi:10.1191/0961203303lu1029oa. PMID 15230295. S2CID 32235606.

europa.eu

ema.europa.eu

"Orencia EPAR". European Medicines Agency (EMA). Retrieved 6 October 2020.

fda.gov

fda.gov

"FDA approves abatacept for prophylaxis of acute graft". U.S. Food and Drug Administration (FDA). 15 December 2021. Archived from the original on 24 January 2022. Retrieved 16 March 2022.

accessdata.fda.gov

"Drug Approval Package: Orencia (Abatacept) NDA #125118". U.S. Food and Drug Administration (FDA). Retrieved 29 December 2020.

healthvalue.net

"ABATACEPT & BELATACEPT: the CTLA-4-Igs". Healthvalue.net. Archived from the original on 5 December 2008. Retrieved 25 May 2007.

medicines.org.uk

"UK label prefilled pen". UK Electronic Medicines Compendium. 25 July 2017.
"UK label powder". UK Electronic Medicines Compendium. 25 July 2017.

nih.gov

pubmed.ncbi.nlm.nih.gov

Moreland L, Bate G, Kirkpatrick P (2006). "Abatacept". Nature Reviews Drug Discovery. 5 (3): 185–186. doi:10.1038/nrd1989. PMID 16557658. S2CID 266176720.
Dall'Era M, Davis J (2004). "CTLA4Ig: a novel inhibitor of co-stimulation". Lupus. 13 (5): 372–376. doi:10.1191/0961203303lu1029oa. PMID 15230295. S2CID 32235606.

dailymed.nlm.nih.gov

"Orencia- abatacept injection, powder, lyophilized, for solution Orencia- abatacept injection, solution". DailyMed. 15 December 2021. Retrieved 16 March 2022.

semanticscholar.org

api.semanticscholar.org

Moreland L, Bate G, Kirkpatrick P (2006). "Abatacept". Nature Reviews Drug Discovery. 5 (3): 185–186. doi:10.1038/nrd1989. PMID 16557658. S2CID 266176720.
Dall'Era M, Davis J (2004). "CTLA4Ig: a novel inhibitor of co-stimulation". Lupus. 13 (5): 372–376. doi:10.1191/0961203303lu1029oa. PMID 15230295. S2CID 32235606.

web.archive.org

"FDA approves abatacept for prophylaxis of acute graft". U.S. Food and Drug Administration (FDA). 15 December 2021. Archived from the original on 24 January 2022. Retrieved 16 March 2022.
"ABATACEPT & BELATACEPT: the CTLA-4-Igs". Healthvalue.net. Archived from the original on 5 December 2008. Retrieved 25 May 2007.